Clinical Trial Update: Right Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE) [Phase 4]

View source ↗

Summary

Phase 4 prospective, single-arm study evaluating the effects of sotatercept on right ventricular function in patients with pulmonary arterial hypertension; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Pulmonary Arterial Hypertension PAH, Pulmonary Arterial Hypertension WHO Group I | Phase 4 | Status: RECRUITING